Glivec in Pediatric Chronic Myeloid Leukemia (CML).
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 10 Oct 2016 Status changed from active, no longer recruiting to completed.
- 20 Feb 2009 New trial record